PrecisemAb Awarded the Title of “2025 Emerging High-Potential Startup”
PrecisemAb Biotech has been honored by the Small and Medium Enterprise Administration, Ministry of Economic Affairs,…
Lock antibody
Read MorePrecisemAb Awarded the Title of “2025 Emerging High-Potential Startup”
PrecisemAb Publishes New Research on Tumor-Selective Activation Antibodies in the International Journal of Biological Macromolecules
We are pleased to share that our latest research article,“Development of a tumor-region-selective activation monoclonal antibody…
Congratulations on PrecisemAb’s winning of Innovative Enterprise Award held by Ministry of Economics Affairs.
This award recognizes our outstanding performance as a startup company and also shows our great market…
Contact Us
+886 7 311 1577
｜Taipei office｜
17F, No. 3, Park St., Nangang Dist., Taipei City 115, Taiwan
｜R&D Center｜
12F, 1st Teaching Building, 100, Shih-Chuan 1st Rd., Sanmin Dist., Kaohsiung 807, Taiwan
